Lots of interesting events coming up this year - hope to see you at one!
February 17-19: The Twelfth NovAliX Conference will
be held for the first time in San Diego! You can read my impressions of the 2018 Boston event here, the 2017 Strasbourg event here, and Teddy's impressions of the 2013 event here, here, and here.
April 13-16: CHI’s Fragment-Based Drug Discovery turns 21, old enough to legally drink in the US! The
longest-running annual fragment event returns as usual to San Diego.
This is part of the larger Drug Discovery Chemistry meeting. You can read impressions of the 2025 meeting, the 2024 meeting, the 2023 meeting, the 2022 meeting, the 2021 virtual meeting, the 2020 virtual meeting, the 2019 meeting, the 2018 meeting, the 2017 meeting, the 2016 meeting; the 2015 meeting here, here, and here; the 2014 meeting here and here; the 2013 meeting here and here; the 2012 meeting; the 2011 meeting; and the 2010 meeting.
May 10-12: Industrial Biostructures of America will be held in Cambridge, MA. The meeting covers all aspects of structural biology including FBLD, membrane proteins, allostery, cryo-EM, machine learning, and more.
September 14-16: Fragments X, RSC-BMCS Tenth Fragment-based Drug Discovery Meeting, will be held in Cambridge, UK. You can read my impressions of the 2024 meeting, the 2013 meeting, and the 2009 meeting.
September 28 to October 1: CHI’s Twenty-Fourth Annual Discovery on Target will be held as always in
Boston. As the name implies this event is more target-focused than
chemistry-focused, but there are always plenty of FBDD-related talks.
You can read my impressions of the 2025 meeting, the 2024 meeting, the 2023 meeting, the 2022 meeting, the 2021 meeting, the 2020 virtual meeting, the 2019 meeting, and the 2018 meeting.
November 10-12: CHI holds its third Drug Discovery Chemistry Europe in
beautiful Barcelona. This will likely include tracks on lead generation,
protein-protein interactions, degraders and glues, and machine learning,
with multiple fragment talks throughout.
Know of anything else? Please leave a comment or drop me a note.
No comments:
Post a Comment